Nucleic acids encoding agonistic antibodies that bind CD40

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10865244
APP PUB NO 20180066053A1
SERIAL NO

15490589

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Isolated monoclonal agonistic antibodies which bind to human CD40 and related antibody-based compositions and molecules are disclosed. Also disclosed are therapeutic and diagnostic methods for using the antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • CELLDEX THERAPEUTICS, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Crocker, Andrea New Hope, US 7 22
Goldstein, Joel Hopewell, US 36 697
He, Lizhen Allentown, US 27 308
Keler, Tibor Pipersville, US 53 897
O'Neill, Tom Washington, US 12 40
Sundarapandiyan, Karuna Kendall Park, US 9 38
Thomas, Lawrence J Easton, US 22 257
Vitale, Laura A Doylestown, US 25 340
Widger, Jenifer Alpha, US 9 30

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 15, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00